ATE462446T1 - Immunogenischen zusammensetzung von lebendigen rotaviren mit verringertem risiko von nebenwirkungen - Google Patents

Immunogenischen zusammensetzung von lebendigen rotaviren mit verringertem risiko von nebenwirkungen

Info

Publication number: ATE462446T1
Authority: AT; Austria
Prior art keywords: administration; composition; vaccine; immunogenic composition; compositions
Prior art date: 2000-01-28

Application number

AT01905127T

Other languages

English (en)

Inventor

Albert Kapikian

Robert Chanock

Stephen Udem

Timo Vesikari

Original Assignee

Us Gov Health & Human Serv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-01-28

Filing date

2001-01-26

Publication date

2010-04-15

2001-01-26 Application filed by Us Gov Health & Human Serv filed Critical Us Gov Health & Human Serv

2010-04-15 Application granted granted Critical

2010-04-15 Publication of ATE462446T1 publication Critical patent/ATE462446T1/de

Links

239000000203 mixture Substances 0.000 title abstract 8
241000702670 Rotavirus Species 0.000 title abstract 2
230000002163 immunogen Effects 0.000 title abstract 2
230000002411 adverse Effects 0.000 title 1
230000000694 effects Effects 0.000 title 1
229960005486 vaccine Drugs 0.000 abstract 2
208000005168 Intussusception Diseases 0.000 abstract 1
229940124859 Rotavirus vaccine Drugs 0.000 abstract 1
201000010099 disease Diseases 0.000 abstract 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
230000028993 immune response Effects 0.000 abstract 1
230000003053 immunization Effects 0.000 abstract 1
238000002649 immunization Methods 0.000 abstract 1
229940038523 live rotavirus vaccine Drugs 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
230000000601 reactogenic effect Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/15—Reoviridae, e.g. calf diarrhea virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/542—Mucosal route oral/gastrointestinal
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/12011—Reoviridae
- C12N2720/12311—Rotavirus, e.g. rotavirus A
- C12N2720/12334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Virology (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Immunology (AREA)
Epidemiology (AREA)
Mycology (AREA)
Microbiology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Communicable Diseases (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Oncology (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

AT01905127T 2000-01-28 2001-01-26 Immunogenischen zusammensetzung von lebendigen rotaviren mit verringertem risiko von nebenwirkungen ATE462446T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US17868900P	2000-01-28	2000-01-28
PCT/US2001/002686 WO2001054718A2 (en)	2000-01-28	2001-01-26	Compositions and method for preventing reactogenicity associated with administration of immunogenic live rotavirus compositions

Publications (1)

Publication Number	Publication Date
ATE462446T1 true ATE462446T1 (de)	2010-04-15

Family

ID=22653531

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT01905127T ATE462446T1 (de)	2000-01-28	2001-01-26	Immunogenischen zusammensetzung von lebendigen rotaviren mit verringertem risiko von nebenwirkungen

Country Status (7)

Country	Link
US (1)	US7431931B2 (de)
EP (1)	EP1251869B1 (de)
AT (1)	ATE462446T1 (de)
AU (1)	AU784344B2 (de)
CA (1)	CA2398428C (de)
DE (1)	DE60141681D1 (de)
WO (1)	WO2001054718A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0503337D0 (en) *	2005-02-17	2005-03-23	Glaxosmithkline Biolog Sa	Compositions
US8168202B2 (en) *	2005-07-07	2012-05-01	The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services	Hexavalent bovine rotavirus reassortant composition designed for use in developing countries
US8470336B2 (en) *	2006-05-25	2013-06-25	Boehringer Ingelheim Vetmedica, Inc.	Vaccination of young animals against Lawsonia intracellularis infections

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4571385A (en)	1983-06-27	1986-02-18	The United States Of America As Represented By The Department Of Health And Human Services	Genetic reassortment of rotaviruses for production of vaccines and vaccine precursors

2001
- 2001-01-26 AT AT01905127T patent/ATE462446T1/de not_active IP Right Cessation
- 2001-01-26 EP EP01905127A patent/EP1251869B1/de not_active Expired - Lifetime
- 2001-01-26 AU AU33040/01A patent/AU784344B2/en not_active Expired
- 2001-01-26 DE DE60141681T patent/DE60141681D1/de not_active Expired - Lifetime
- 2001-01-26 US US10/181,908 patent/US7431931B2/en not_active Expired - Lifetime
- 2001-01-26 CA CA2398428A patent/CA2398428C/en not_active Expired - Lifetime
- 2001-01-26 WO PCT/US2001/002686 patent/WO2001054718A2/en not_active Ceased

Also Published As

Publication number	Publication date
CA2398428A1 (en)	2001-08-02
AU784344B2 (en)	2006-03-16
US20040223981A1 (en)	2004-11-11
US7431931B2 (en)	2008-10-07
DE60141681D1 (de)	2010-05-12
EP1251869B1 (de)	2010-03-31
AU3304001A (en)	2001-08-07
CA2398428C (en)	2015-09-08
WO2001054718A3 (en)	2002-04-18
WO2001054718A2 (en)	2001-08-02
EP1251869A2 (de)	2002-10-30

Similar Documents

Publication	Publication Date	Title
JP2012506411A5 (de)	2012-12-06
MA51048B1 (fr)	2025-12-31	Compositions comprenant des conjugues de polysaccharide-proteine de streptococcus pneumoniae et leurs procedes d'utilisation
ES2257769T3 (es)	2006-08-01	Metodo para la preparacion de vacunas multivalentes.
NO20015073D0 (no)	2001-10-18	Vaksiner
EA200701519A1 (ru)	2008-02-28	Живая аттенуированная ротавирусная вакцина для перорального введения
RU2011120706A (ru)	2012-11-27	Композиции вакцин, содержащие мутированный белок, связывающий фактор н
ES2118815T3 (es)	1998-10-01	Virus de la seudorrabia, s-prv-155, atenuado y obtenido por ingenieria genetica y sus usos.
WO2005116270A3 (en)	2007-12-21	Influenza virus vaccine composition and method of use
BR0007936A (pt)	2002-04-09	Composto, formulação adjuvante imunológica, formulação de vacina, e, processo para estimular uma resposta imune a um antìgeno
JP2013542224A5 (de)	2014-12-18
AR034270A1 (es)	2004-02-18	1-aril- o 1-alquilsulfonil-heterociclilbenzazoles como ligandos de 5-hidroxitriptamina-6, un metodo para su preparacion, una composicion farmaceutica y el uso de los mismos para la manufactura de un medicamento
BR9915852A (pt)	2004-06-29	Conjugado de hapteno-portador para tratamento e prevenção do vìcio da nicotina
NO179125C (no)	1996-08-14	Preparat for forbedring av implantasjon av et embryo i uterus hos et hunnpattedyr
DK1740217T3 (da)	2011-09-26	Meningokok-konjugat-vaccination
WO2002032923A3 (en)	2002-08-01	Improved formulations using heat shock/stress protein-peptide complexes
WO2005074460A3 (en)	2005-09-29	Methods of enhancing immune response in the intradermal compartment and compounds useful in the methods
ATE416788T1 (de)	2008-12-15	Verwendung von pflanzen-öl-körper in impfstoffverabreichungsysteme
Falsey et al.	2023	Respiratory syncytial virus prefusion F vaccine
ATE462446T1 (de)	2010-04-15	Immunogenischen zusammensetzung von lebendigen rotaviren mit verringertem risiko von nebenwirkungen
JP2020536098A5 (de)	2021-08-12
WO1999053950A3 (en)	2000-01-13	Live vaccines and methods of treatment therewith
BRPI9912485B8 (pt)	2021-05-25	composição imunogênica multivalente
ES2358420T3 (es)	2011-05-10	Cápsula blanda de nlkj (lípidos neutros obtenidos de semillas de lágrimas de job) para el tratamiento de enfermedades de la próstata.
DK0563254T3 (da)	1996-02-12	Anvendelse af IL-4 til forstærkning af immunrespons på immunogener i vacciner
CA2354045A1 (en)	2000-06-15	New cancer treatments

Legal Events

Date	Code	Title	Description
2010-09-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties